C4 Therapeutics Company
TORPEDO® platform to design and optimize targeted protein degraders (TPDs).
Total Funding:
> $700 M
Industry:
Deep Diagnostics
Headquarters:
USA
Technology:
Genetic Test & Molecular Diagnostics
Funding Status:
IPO
Founded Date:
2015
Estimated Revenue:
$1M to $10M